Hjem
Kimberley Joanne Hatfields bilde

Kimberley Joanne Hatfield

Forsker, Leukemia Research Group
  • E-postKimberley.Hatfield@uib.no
  • Telefon+47 55 97 30 37
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen

Prosjektet undersøker effekten av ulike medikamenter som blokkerer sentrale metabolske signalveier i akutt myeloid leukemi (AML). Prosjektet har som mål å karakterisere ulike metabolske signalveier i leukemiceller, samt autofagi, og studere hvordan dette bidrar til kjemoresistens i AML. Prosjektet er støttet av midler fra Bergens forskningsstiftelse.

  • Melve, Guro Kristin; Ersvær, Elisabeth; Rye, Kristin Paulsen; Ahmed, Aymen B; Kristoffersen, Einar Klæboe; Hervig, Tor; Reikvam, Håkon; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2018. The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis. Cytotherapy. 20: 740-754. doi: 10.1016/j.jcyt.2018.02.366
  • Nepstad, Ina; Hatfield, Kimberley Joanne; Aasebø, Elise; Hernandez-Valladares, Maria; Brenner, Annette; Bartaula-Brevik, Sushma; Berven, Frode; Selheim, Frode; Skavland, Jørn; Gjertsen, Bjørn Tore; Reikvam, Håkon; Bruserud, Øystein. 2018. Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic and transcriptomic comparison. Expert opinion on therapeutic targets. 22: 639-653. doi: 10.1080/14728222.2018.1487401
  • Nepstad, Ina; Hatfield, Kimberley Joanne; Tvedt, Tor Henrik Anderson; Reikvam, Håkon; Bruserud, Øystein. 2018. Clonal heterogeneity reflected by pi3k-akt-mtor signaling in human acute myeloid leukemia cells and its association with adverse prognosis. Cancers. 10:332: 1-15. doi: 10.3390/cancers10090332
  • Nepstad, Ina; Reikvam, Håkon; Brenner, Annette; Bruserud, Øystein; Hatfield, Kimberley Joanne. 2018. Resistance to the antiproliferative in vitro effect of PI3K-Akt-mTOR inhibition in primary human acute myeloid leukemia cells is associated with altered cell metabolism. International Journal of Molecular Sciences. 19:382: 1-18. doi: 10.3390/ijms19020382
  • Reikvam, Håkon; Grønningsæter, Ida Sofie; Mosevoll, Knut Anders; Lindås, Roald; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2018. Patients with treatment-requiring chronic graft versus host disease after allogeneic stem cell transplantation have altered metabolic profiles due to the disease and immunosuppressive therapy: Potential implication for biomarkers. Frontiers in Immunology. 8:1979: 1-15. doi: 10.3389/fimmu.2017.01979
  • Hatfield, Kimberley Joanne; Melve, Guro Kristin; Bruserud, Øystein. 2017. Granulocyte colony-stimulating factor alters the systemic metabolomic profile in healthy donors. Metabolomics. 13:2: 1-10. doi: 10.1007/s11306-016-1139-x
  • Hauge, Michelle Victoria; Bruserud, Øystein; Hatfield, Kimberley Joanne. 2016. Targeting of cell metabolism in human acute myeloid leukemia - more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling? European Journal of Haematology. 96: 211-221. doi: 10.1111/ejh.12690
  • Kallekleiv, Marit Selvik; Larun, Lillebeth; Bruserud, Øystein; Hatfield, Kimberley Joanne. 2016. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Cytotherapy. 18: 172-185. doi: 10.1016/j.jcyt.2015.11.010
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2016. The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation. Metabolomics. 12. doi: 10.1007/s11306-015-0880-x
  • Reikvam, Håkon; Grønningsæter, Ida Sofie; Ahmed, Aymen B; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2015. Metabolic serum profiles for patients receiving allogeneic stem cell transplantation: the pretransplant profile differs for patients with and without posttransplant capillary leak syndrome. Disease Markers. 2015:943430. 13 sider. doi: 10.1155/2015/943430

Se fullstendig oversikt over publikasjoner i CRIStin.

2016-2020: Metabolic phenotypes of leukemia cells.